Intrexon | XON - Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
Agenus USD 39.21M 49.82M 2026-03
Alaunos Therapeutics USD -7.84M 633K 2023-12
Amgen USD 2.08B 570M 2026-03
Anika Therapeutics USD 764K 3M 2025-12
Arrowhead Research USD -178.9M 41.34M 2026-06
AstraZeneca USD 4.81B 894M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Incyte USD 751.51M 407.91M 2026-06
Intrexon USD -60.48M 27.09M 2024-06
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
Ligand Pharmaceuticals USD -24.26M 81.04M 2026-03
MacroGenics USD -36.77M 21.84M 2026-03
MannKind USD -16.37M 4.56M 2026-03
Merck USD -3.53B 6.95B 2026-03
Novartis USD 4.27B 430M 2026-06
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Veracyte USD 26.52M 3.45M 2026-06
Xencor USD -21.92M 106.72M 2026-06